Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In Changsha
This study is completed in the United Kingdom. It focuses on ADHD.
In LondonThis study is completed in Portugal. It focuses on schizophrenia.
In PortoThis study is completed in Australia. It is testing 18-Methoxycoronaridine (18-MC HCl) for Addiction.
In PerthThis study was terminated in the United States. It is testing adverse Events of Fosigotifator for depression.
Multiple locations, including Sherman OaksThis study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
Multiple locations, including PhoenixThis study is completed in the United States. It is testing KarXT for schizophrenia.
Multiple locations, including Little RockThis study is completed in the United States and in Ukraine. It is testing KarXT for schizophrenia.
Multiple locations, including BentonvilleThis study was withdrawn in the United States. It is testing Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression.
Multiple locations, including New Haven
This study is completed in Belgium. It is testing learning Performance for schizophrenia.
In DuffelThis study is completed in the United States. It is testing Safety and Efficacy of KarXT for schizophrenia.
Multiple locations, including Little RockThis study is completed. It is testing Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone for schizophrenia.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.